ROUND CELL SARCOMA WITH EWSR1-NON-ETS FUSION

Clinical trials for ROUND CELL SARCOMA WITH EWSR1-NON-ETS FUSION explained in plain language.

Never miss a new study

Get alerted when new ROUND CELL SARCOMA WITH EWSR1-NON-ETS FUSION trials appear

Sign up with your email to follow new studies for ROUND CELL SARCOMA WITH EWSR1-NON-ETS FUSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for young patients with spreading bone cancer

Disease control Ongoing

This trial is testing whether adding two new drugs, irinotecan and regorafenib, to standard chemotherapy works better for young patients with Ewing sarcoma that has spread. It aims to see if this combination helps patients live longer without their cancer returning. The study is …

Matched conditions: ROUND CELL SARCOMA WITH EWSR1-NON-ETS FUSION

Phase: PHASE2, PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

ROUND CELL SARCOMA WITH EWSR1-NON-ETS FUSION

Get alerted when new ROUND CELL SARCOMA WITH EWSR1-NON-ETS FUSION trials appear

New hope for young patients with spreading bone cancer